Focus
ibd
New, Cheaper IBD Drugs Approved in US: What You Need to Know
More than 3 million U.S. adults live with inflammatory bowel disease (IBD), a medical condition encompassing Crohn’s disease and ulcerative colitis. These sometimes painful conditions are characterized by persistent inflammation in the gastrointestinal tract (GI), leading to potential GI damage.
